Therefore, identification of a distinct subpopulation of NOTCH3+ cells among normal tissues, which specifically generates neointimal lesions, provides novel avenues for therapeutic development in PAH. The gene discussed is NOTCH3; the disease is pulmonary arterial hypertension.